Cancer of the Bones and Joints – Cancer Stat Facts
Bone and Joint Cancer statistics
Bone and Joint Cancer statistics
Alberto Olaya-Vargas speaks exclusively to VJHemOnc , The Video Journal of Hematological Oncology. Watch interviews and discussions with Alberto Olaya-Vargas here.
Researchers have developed a model for predicting recurrence-free and melanoma-specific survival after sentinel lymph node biopsy (SLNB) in patients with melanoma.
CAR T-cell therapy is effective and tolerable in patients with mantle cell lymphoma with secondary central nervous system involvement.
During a Case-Based Roundtable® event, Abdullah Khan, MBBS, discussed the different outcomes with idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma in both the clinic…
Conformationally insensitive nanobodies activate VWF binding of platelets by disrupting its NAIM.Conformationally sensitive nanobodies inhibit VWF binding
FDA has accepted the Bristol Myers Squibb’s Biologics License Application for the subcutaneous formulation of Opdivo (nivolumab) co-formulated with Halozyme’s proprietary recombinant human hyaluronidase (rHuPH20)—herein…
AbstractBackground:. Ultrafine particles (UFP) are unregulated air pollutants abundant in aviation exhaust. Emerging evidence suggests that UFPs may impact lung health due to their high…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
The National Institutes of Health (NIH) has launched the Cancer Screening Research Network, a clinical trials network to evaluate emerging cancer screening technologies. The new…